Ligand Pharmaceuticals Incorporated
Ligand Pharmaceuticals Incorporated (LGND) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · LGND · as of Jun 9, 2026
Key Statistics
Explore Ligand Pharmaceuticals Incorporated Data
lgnd stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 17 · Buy rate: 70.6%
The LGND analyst consensus is Buy, based on ratings from 17 Wall Street analysts over the past 3 months. The average 12-month price target is $267.75, representing +12.62% upside from the current price of $237.75.
Competitors & Peers
lgnd competitorsLGND
ACAD
ADMA
BLTE
CRNX
DYNStock Performance
Full HistoryAbout Ligand Pharmaceuticals Incorporated
Ligand Pharmaceuticals Incorporated operates as a biopharmaceutical entity, primarily engaged in sourcing and advancing technologies to empower pharmaceutical companies globally in their efforts to di…
what is ligand pharmaceuticals incorporated · lgnd stock overview · ligand pharmaceuticals incorporated company profile · who is ligand pharmaceuticals incorporated ceo · lgnd NASDAQ · ligand pharmaceuticals incorporated headquarters · ligand pharmaceuticals incorporated business segments
About Stock Overview & Key Data
Ligand Pharmaceuticals Incorporated (LGND) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Nov 18, 1992. As of the latest trading session, LGND stock price is $237.75, with a market capitalization of $4.8B. The stock has returned +117.16% over the past 12 months and +25.75% year-to-date.
According to 17 Wall Street analysts, the consensus rating for Ligand Pharmaceuticals Incorporated stock is Buy, with an average 12-month price target of $267.75. In fiscal year 2025, Ligand Pharmaceuticals Incorporated reported revenue of $268.1M and net income of $124.5M. For detailed data — including Ligand Pharmaceuticals Incorporated revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Ligand Pharmaceuticals Incorporated (LGND) stock price is $237.75. The stock is traded on NASDAQ under the ticker symbol LGND. The 52-week range is $106.30 – $247.38.